Page last updated: 2024-08-21

thiazolidines and Weight Gain

thiazolidines has been researched along with Weight Gain in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (50.00)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fukuda-Tsuru, S; Ishii, S; Kakimoto, T; Kiuchi, S; Utsumi, H1
Ahn, JH; Cha, BS; Choi, CS; Kang, ES; Kim, YW; Lee, BW; Lee, EY; Lee, HC; Oh, H1
Avery, MA; Benson, SC; Chittiboyina, A; Desai, P; Ho, CI; Kurtz, TW; Pershadsingh, HA; Pravenec, M; Qi, N; Wang, J1
Auld, PA; Frayer, WW; Jain, A; Madsen, DC; MÃ¥rtensson, J; Meister, A; Schwartz, MK1
Bussi, R; Cavalletti, E; Ceserani, R; Montaguti, P; Tognella, S1
Baker, DH; Chung, TK; Funk, MA1

Other Studies

6 other study(ies) available for thiazolidines and Weight Gain

ArticleYear
The novel dipeptidyl peptidase-4 inhibitor teneligliptin prevents high-fat diet-induced obesity accompanied with increased energy expenditure in mice.
    European journal of pharmacology, 2014, Jan-15, Volume: 723

    Topics: Adipocytes; Adipose Tissue, White; Animals; Anti-Obesity Agents; Diet, High-Fat; Dipeptidyl-Peptidase IV Inhibitors; Energy Metabolism; Lipid Metabolism; Liver; Male; Mice; Mice, Inbred C57BL; Motor Activity; Obesity; Organ Size; Oxygen Consumption; Pyrazoles; Thiazolidines; Weight Gain

2014
Anti-obesity effects of KR-66195, a synthetic DPP-IV inhibitor, in diet-induced obese mice and obese-diabetic ob/ob mice.
    Metabolism: clinical and experimental, 2014, Volume: 63, Issue:6

    Topics: Animals; Anti-Obesity Agents; Blood Glucose; Body Composition; Diabetes Mellitus; Diet, High-Fat; Dipeptidyl Peptidase 4; Eating; Energy Metabolism; Enzyme Inhibitors; Female; Glucagon-Like Peptide 1; Glucose Tolerance Test; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Obesity; Random Allocation; Thiazolidines; Treatment Outcome; Valine; Weight Gain

2014
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity.
    Hypertension (Dallas, Tex. : 1979), 2004, Volume: 43, Issue:5

    Topics: Adipocytes; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Biphenyl Compounds; Blood Glucose; Cell Differentiation; Cells, Cultured; Chlorocebus aethiops; Drug Evaluation, Preclinical; Gene Expression Regulation; Imidazoles; Insulin; Irbesartan; Losartan; Male; Mice; Models, Molecular; Myoblasts; Protein Conformation; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Structure-Activity Relationship; Telmisartan; Tetrazoles; Thiazoles; Thiazolidinediones; Thiazolidines; Transcription Factors; Triglycerides; Valine; Valsartan; Weight Gain

2004
L-2-oxothiazolidine-4-carboxylate, a cysteine precursor, stimulates growth and normalizes tissue glutathione concentrations in rats fed a sulfur amino acid-deficient diet.
    The Journal of nutrition, 1995, Volume: 125, Issue:4

    Topics: Amino Acids, Sulfur; Animals; Bronchoalveolar Lavage Fluid; Diet; Glutathione; Growth; Liver; Lung; Lymphocytes; Male; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Sprague-Dawley; Thiazoles; Thiazolidines; Weight Gain

1995
Reproductive toxicology of the new antitussive moguisteine.
    Arzneimittel-Forschung, 1994, Volume: 44, Issue:12

    Topics: Abnormalities, Drug-Induced; Animals; Antitussive Agents; Embryo, Mammalian; Female; Fertility; Growth; Labor, Obstetric; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rabbits; Rats; Rats, Sprague-Dawley; Reproduction; Teratogens; Thiazoles; Thiazolidines; Weight Gain

1994
L-2-oxothiazolidine-4-carboxylate as a cysteine precursor: efficacy for growth and hepatic glutathione synthesis in chicks and rats.
    The Journal of nutrition, 1990, Volume: 120, Issue:2

    Topics: Administration, Oral; Animals; Chickens; Cysteine; Diet; Glutathione; Liver; Male; Pyrrolidonecarboxylic Acid; Random Allocation; Rats; Rats, Inbred Strains; Regression Analysis; Thiazoles; Thiazolidines; Weight Gain

1990